MedTrace Logo

Development of a Minimally Invasive Seizure Gauge

NCT03882671 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-05-15

No results posted yet for this study

Summary

The researchers are trying to assess changes in physiological signals before and during seizures.

Conditions

Interventions

DEVICE

EpiTel Epilog

EEG recording device

DEVICE

Empatica E4

PPG, sweat level, temperature and accelerometry recording device

DEVICE

GENEActiv

Temperature, light level and accelerometry recording device

Sponsors & Collaborators

  • Seer Medical Pty Ltd

    lead INDUSTRY

Principal Investigators

  • Dean R Freestone, PhD BEng · CEO

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03882671 on ClinicalTrials.gov